Parkhurst A. Shore - Publications

Affiliations: 
University of Texas Southwestern Medical Center, Dallas, TX, United States 
Area:
Pharmacology, monoamines

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1984 Matthews RT, McMillen BA, Speciale SG, Jarrah H, Shore PA, Sanghera MK, Shepard PD, German DC. Effects of zoxazolamine and related centrally acting muscle relaxants on nigrostriatal dopaminergic neurons. Brain Research Bulletin. 12: 479-86. PMID 6467036 DOI: 10.1016/0361-9230(84)90163-1  0.572
1981 German DC, McMillen BA, Sanghera MK, Saffer SI, Shore PA. Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation. Brain Research Bulletin. 6: 131-4. PMID 6110470 DOI: 10.1016/S0361-9230(81)80037-8  0.576
1980 McMillen BA, Shore PA. Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity. Naunyn-Schmiedeberg's Archives of Pharmacology. 313: 39-44. PMID 6111026 DOI: 10.1007/BF00505803  0.593
1980 McMillen BA, German DC, Shore PA. Functional and pharmacological significance of brain dopamine and norepinephrine storage pools. Biochemical Pharmacology. 29: 3045-50. PMID 6109535 DOI: 10.1016/0006-2952(80)90444-X  0.637
1980 McMillen BA, German DC, Sanghere MK, Warnack W, Shore PA. Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors. The Journal of Pharmacology and Experimental Therapeutics. 215: 150-5. PMID 6109013  0.595
1980 McMillen BA, Warnack W, German DC, Shore PA. Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs. European Journal of Pharmacology. 61: 239-46. PMID 6102522 DOI: 10.1016/0014-2999(80)90126-0  0.587
1979 German DC, Sanghera MK, Kiser RS, McMillen BA, Shore PA. Electrophysiological and biochemical responses of noradrenergic neurons to a non-amphetamine CNS stimulant. Brain Research. 166: 331-9. PMID 427592 DOI: 10.1016/0006-8993(79)90218-X  0.619
1979 McMillen BA, Shore PA. Species-dependent responsiveness to nonamphetamine central stimulants. Relationship between uptake and release of brain dopamine. Pharmacology. 19: 261-6. PMID 43984 DOI: 10.1159/000137321  0.613
1979 McMillen BA, Warnack W, German DC, Shore PA. Effects of chronic desipramine (DMI) treatment on rat brain noradrenergic responses to alpha-adrenergic drugs Federation Proceedings. 38: No. 1926.  0.58
1978 McMillen BA, Shore PA. Comparative effects of clozapine and alpha-adrenoceptor blocking drugs on regional noradrenaline metabolism in rat brain. European Journal of Pharmacology. 52: 225-30. PMID 32048 DOI: 10.1016/0014-2999(78)90210-8  0.61
1978 McMillen BA, Shore PA. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems. The Journal of Pharmacy and Pharmacology. 30: 464-6. PMID 27622  0.605
1978 McMillen BA, Shore PA. Specific actions of a nonamphetamine stimulant, amfonelic acid (AFA), on dopamine (DA) neurons: Association with differences in DA and norepinephrine (NE) storage Federation Proceedings. 37: No. 2747.  0.586
1977 McMillen BA, Shore PA. The relative functional availability of brain noradrenaline and dopamine storage pools. The Journal of Pharmacy and Pharmacology. 29: 780-1. PMID 22634  0.631
1974 Enna SJ, Shore PA. Differences in amine storage in rat heart and brain. British Journal of Pharmacology. 50: 271-6. PMID 4425766  0.41
1974 Enna SJ, Shore PA. On the nature of the adrenergic neuron extragranular amine binding site. Journal of Neural Transmission. 35: 125-35. PMID 4152377 DOI: 10.1007/BF01250740  0.41
1973 Enna SJ, Dorris RL, Shore PA. Specific inhibition by -methyltyrosine of amphetamine-induced amine release from brain. The Journal of Pharmacology and Experimental Therapeutics. 184: 576-82. PMID 4687221  0.41
1972 Enna SJ, Shore PA. Characteristics of storage and release of metaraminol in the rat heart. Biochemical Pharmacology. 21: 1535-42. PMID 4646783 DOI: 10.1016/0006-2952(72)90302-4  0.41
1971 Enna SJ, Shore PA. Regional distribution of persistently bound reserpine in rat brain. Biochemical Pharmacology. 20: 2910-2. PMID 5114522 DOI: 10.1016/0006-2952(71)90204-8  0.41
1961 KUNTZMAN R, SHORE PA, BOGDANSKI D, BRODIE BB. Microanalytical procedures for fluorometric assay of brain DOPA-5HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain. Journal of Neurochemistry. 6: 226-32. PMID 13755185 DOI: 10.1111/J.1471-4159.1961.Tb13469.X  0.57
1960 SPECTOR S, SHORE PA, BRODIE BB. On the reported inhibition of monoamine oxidase by an agent with sedative properties. Science (New York, N.Y.). 132: 735. PMID 13833206 DOI: 10.1126/Science.132.3429.735  0.553
1960 SPECTOR S, SHORE PA, BRODIE BB. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835). The Journal of Pharmacology and Experimental Therapeutics. 128: 15-21. PMID 13833205  0.44
1959 QUINN GP, SHORE PA, BRODIE BB. Biochemical and pharmacological studies of RO 1-9569 (tetrabenazine), a nonindole tranquilizing agent with reserpine-like effects. The Journal of Pharmacology and Experimental Therapeutics. 127: 103-9. PMID 14435563  0.407
1959 PROCKOP DJ, SHORE PA, BRODIE BB. Anticonvulsant properties of monoamine oxidase inhibitors. Annals of the New York Academy of Sciences. 80: 643-51. PMID 14434994 DOI: 10.1111/J.1749-6632.1959.Tb49242.X  0.471
1959 BRODIE BB, SPECTOR S, SHORE PA. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. Annals of the New York Academy of Sciences. 80: 609-16. PMID 13804624 DOI: 10.1111/J.1749-6632.1959.Tb49239.X  0.565
1959 BRODIE BB, SPECTOR S, SHORE PA. Interaction of drugs with norepinephrine in the brain. Pharmacological Reviews. 11: 548-64. PMID 13667433  0.506
1959 PROCKOP DJ, SHORE PA, BRODIE BB. An anticonvulsant effect of monoamine oxidase inhibitors. Experientia. 15: 145-7. PMID 13652972 DOI: 10.1007/Bf02165531  0.514
1958 BRODIE BB, PROCKOP DJ, SHORE PA. An interpretation of the action of psychotropic drugs. Postgraduate Medicine. 24: 296-304. PMID 13591092 DOI: 10.1080/00325481.1958.11692214  0.477
1958 HUGHES FB, SHORE PA, BRODIE BB. Serotonin storage mechanism and its interaction with reserpine. Experientia. 14: 178-80. PMID 13548127 DOI: 10.1007/Bf02158651  0.497
1958 SHORE PA, BRODIE BB. Effect of iproniazid on brain levels of norepinephrine and serotonin. Science (New York, N.Y.). 127: 704. PMID 13529039 DOI: 10.1126/Science.127.3300.704  0.602
1958 Biel JH, Drukker AE, Shore PA, Spector S, Brodie BB. Effect Of 1-Phenyl-2-Hydrazinopropane, A Potent Monoamine Oxidase (Mao) Inhibitor, On Brain Levels Of Norepinephrine And Serotonin Journal of the American Chemical Society. 80: 1519-1519. DOI: 10.1021/Ja01539A061  0.602
1958 Brodie BB, Spector S, Kuntzman RG, Shore PA. Rapid biosynthesis of brain serotonin before and after reserpine administration Die Naturwissenschaften. 45: 243-244. DOI: 10.1007/Bf00602706  0.612
1957 SHORE PA, MEAD JA, KUNTZMAN RG, SPECTOR S, BRODIE BB. On the physiologic significance of monoamine oxidase in brain. Science (New York, N.Y.). 126: 1063-4. PMID 13486059 DOI: 10.1126/Science.126.3282.1063  0.579
1957 UDENFRIEND S, SHORE PA, BOGDANSKI DF, WEISSBACH H, BRODIE BB. Biochemical, physiological, and pharmacological aspects of serotonin. Recent Progress in Hormone Research. 13: 1-13; discussion 14-. PMID 13477804  0.479
1957 SCHANKER LS, SHORE PA, BRODIE BB, HOGBEN CA. Absorption of drugs from the stomach. I. The rat. The Journal of Pharmacology and Experimental Therapeutics. 120: 528-39. PMID 13476377  0.397
1957 CARLSSON A, SHORE PA, BRODIE BB. Release of serotonin from blood platelets by reserpine in vitro. The Journal of Pharmacology and Experimental Therapeutics. 120: 334-9. PMID 13476355  0.431
1957 BRODIE BB, OLIN JS, KUNTZMAN RG, SHORE PA. Possible interrelationship between release of brain norepinephrine and serotonin by reserpine. Science (New York, N.Y.). 125: 1293-4. PMID 13432798 DOI: 10.1126/Science.125.3261.1293  0.605
1957 BRODIE BB, TOMICH EG, KUNTZMAN R, SHORE PA. On the mechanism of action of reserpine: effect of reserpine on capacity of tissues to bind serotonin. The Journal of Pharmacology and Experimental Therapeutics. 119: 461-7. PMID 13429453  0.427
1957 BRODIE BB, SHORE PA. A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Annals of the New York Academy of Sciences. 66: 631-42. PMID 13425246 DOI: 10.1111/J.1749-6632.1957.Tb40753.X  0.586
1957 SHORE PA, PLETSCHER A, TOMICH EG, CARLSSON A, KUNTZMAN R, BRODIE BB. Role of brain serotonin in reserpine action. Annals of the New York Academy of Sciences. 66: 609-15; discussion, . PMID 13425244 DOI: 10.1111/J.1749-6632.1957.Tb40751.X  0.603
1957 HAVERBACK BJ, DUTCHER TF, SHORE PA, TOMICH EG, TERRY LL, BRODIE BB. Serotonin changes in platelets and brain induced by small daily doses of reserpine; lack of effect of depletion of platelet serotonin on hemostatic mechanisms. The New England Journal of Medicine. 256: 343-5. PMID 13418998 DOI: 10.1056/Nejm195702212560804  0.506
1957 SHORE PA, BRODIE BB, HOGBEN CA. The gastric secretion of drugs: a pH partition hypothesis. The Journal of Pharmacology and Experimental Therapeutics. 119: 361-9. PMID 13417090  0.376
1957 SHORE PA, BRODIE BB. LSD-like effects elicited by reserpine in rabbits pretreated with iproniazid. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 94: 433-5. PMID 13408282 DOI: 10.3181/00379727-94-22968  0.58
1956 BRODIE BB, HESS SM, SHORE PA. Persistence of reserpine action after the disappearance of drug from brain: effect on serotonin. The Journal of Pharmacology and Experimental Therapeutics. 118: 84-9. PMID 13368044  0.559
1956 SHORE PA, PLETSCHER A, TOMICH EG, KUNTZMAN R, BRODIE BB. Release of blood platelet serotonin by reserpine and lack of effect on bleeding time. The Journal of Pharmacology and Experimental Therapeutics. 117: 232-6. PMID 13332567  0.431
1956 PLETSCHER A, SHORE PA, BRODIE BB. Serotonin as a mediator of reserpine action in brain. The Journal of Pharmacology and Experimental Therapeutics. 116: 84-9. PMID 13296021  0.566
1955 BRODIE BB, SHORE PA, SILVER SL. Potentiating action of chlorpromazine and reserpine. Nature. 175: 1133-4. PMID 14394132 DOI: 10.1038/1751133A0  0.498
1955 BRODIE BB, PLETSCHER A, SHORE PA. Evidence that serotonin has a role in brain function. Science (New York, N.Y.). 122: 968. PMID 13274056 DOI: 10.1126/Science.122.3177.968  0.579
1955 PLETSCHER A, SHORE PA, BRODIE BB. Serotonin release as a possible mechanism of reserpine action. Science (New York, N.Y.). 122: 374-5. PMID 13246642 DOI: 10.1126/Science.122.3165.374  0.521
1955 SHORE PA, SILVER SL, BRODIE BB. Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (New York, N.Y.). 122: 284-5. PMID 13246633 DOI: 10.1126/Science.122.3163.284-A  0.57
1955 SHORE PA, SILVER SL, BRODIE BB. Interaction of serotonin and lysergic acid diethylamide (LSD) in the central nervous system. Experientia. 11: 272-3. PMID 13241495 DOI: 10.1007/Bf02161252  0.521
1955 SHORE PA, AXELROD J, HOGBEN CA, BRODIE BB. Observations on the fate of dromoran in the dog and its secretion into the gastric juice. The Journal of Pharmacology and Experimental Therapeutics. 113: 192-9. PMID 13234042  0.339
1954 BRODIE BB, AXELROD J, SHORE PA, UDENFRIEND S. Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen. The Journal of Biological Chemistry. 208: 741-50. PMID 13174583  0.35
Show low-probability matches.